A novel assay for detection of hepatitis C virus-specific effector CD4 + T cells via co-expression of CD25 and CD134

Journal of Immunological Methods

Volumn 375, Issue 1-2, 2012, Pages 148-158

  Keoshkerian, Elizabeth ^a   Helbig, Karla ^b   Beard, Michael ^b   Zaunders, John ^c   Seddiki, Nabila ^d   Kelleher, Anthony ^d   Hampartzoumian, Taline ^a   Zekry, Amany ^a   Lloyd, Andrew R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c HIV Immunovirology Research Laboratory   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antigen specific CD4 T cells; CD134; CD25; Hepatitis C virus

Indexed keywords

CD134 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; VIRUS PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; EFFECTOR CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; CRYOPRESERVATION; CYTOKINES; DNA-DIRECTED RNA POLYMERASES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, OX40; RECOMBINANT PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 84855349476     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.10.004     Document Type: Article

References (40)

1. + T-cell response in acute hepatitis C primary infection and reinfection. J. Clin. Virol. 2006, 36:24.
2. Bukh J., Miller R., Purcell R.H. Genetic heterogeneity of hepatitis virus C: quasispecies and genotypes. Semin. Liver Dis. 1995, 15:41.
3. Bull R.A., Eden J.S., Rawlinson W.D., White P.A. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 2010, 6(3):e1000831.
4. + responsiveness in Hepatitis C virus infection. Hepatology 2001, 33(1):267.
5. Combet C., Penin F., Geourjon C., Deléage G. HCVDB: Hepatitis C virus sequences database. Appl. Bioinformatics 2004, 3:237.
6. Cooper S., Erickson A.L., Adams E.J., Kansopon J., Weiner A.J., Chien D.Y., Houghton M., Parham P., Walker C.M. Analysis of a successful immune response against hepatitis C virus. Immunity 1999, 10:439.
7. Croft M. Co-stimulatory members of the TNFR family: keys to effective T cell immunity?. Nat. Rev. Immunol. 2003, 3:609.
8. + T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 2002, 76:12584.
9. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., Eichenlaub D., Pape G.R. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995, 346:1006.
10. + T lymphocytes in acute and chronic hepatitis C. J. Mol. Med. 1996, 74:583.
11. Dolan K., Teutsch S., Scheuer N., Levy M., Rawlinson W., Kaldor J., Lloyd A., Haber P. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur. J. Epidemiol. 2010, 25:143.
12. Folgori, A., Spada, E., et al., Pezzanera, M., Ruggeri, L., Mele, A., Garbuglia, A.R., Perrone, M.P., Del Porto, P., Piccolella, E., Cortese, R., Nicosia, A., Vitelli, A., 2006. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55, 1012.
13. Frick D.N. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr. Issues Mol. Biol. 2007, 9:1.
14. + T cell response in acute hepatitis C. Gastroenterology 1999, 117:933.
15. Grakoui A., Shoukry N.H., Woollard D.J., Han J.H., Hanson H.L., Ghrayeb J., Murthy K.K., Rice C.M., Walker C.M. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003, 302:659.
16. Helbig K.J., Ruszkiewicz A., Lanford R.E., Berzsenyi M.D., Harley H.A., McColl S.R., Beard M.R. Differential expression of the CXCR3 ligands in chronic Hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J. Virol. 2009, 83(2):836.
17. Kaplan D.E., Sugimoto K., Newton K., Valiga M.E., Ikeda F., Aytaman A., Nunes F.A., Lucey M.R., Vance B.A., Vonderheide R.H., Reddy K.R., McKeating J.A., Chang K.-M. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. Gastroenterology 2007, 132:654.
18. Kiken C., Yusim K., Boykin L., Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005, 21:379.
19. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000, 191:1499.
20. Lenardo M., Chan K.M., Hornung F., McFarland H., Sigel R., Wang J., Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999, 17:221.
21. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., Rumi M.G., Houghton M., Fiaccadori F., Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 1996, 98:706.
22. Neumann-Haefelin C., Killinger T., Timm J., Southwood S., McKinney D., Blum H.E., Thimme R. Absence of viral escape within a frequently recognized HLA-A26-restricted CD8 T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. J. Gen. Virol. 2007, 88:1986.
23. Neumann-Haefelin C., Frick D.N., Wang J.J., Pybus O.G., Salloum S., Narula G.S., Eckart A., Biezynski A., Eiermann T., Klenerman P., Viazov S., Roggendorf M., Thimme R., Reiser M., Timm J. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. J. Virol. 2008, 82:3438.
24. Pape G.R., Gerlach T.J., Diepolder H.M., Grüner N., Jung M., Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. J. Viral Hepatol. 1999, 6(Suppl 1):36.
25. Rehermann B., Naumov N. Immunological techniques in viral hepatitis. J. Hepatol. 2007, 46:508.
26. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 1996, 98:1432.
27. + T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002, 35:190.
28. + Th cell response in spontaneously controlled Hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 2005, 175:3603.
29. Shata M.T., Anthony D.D., Carlson N.L., Andrus L., Brotman B., Tricoche N., McCormack P., Prince A. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J. Viral Hepatol. 2002, 9:400.
30. + T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 2003, 197:1645.
31. Simmonds P., Bukh J. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962.
32. Smyk-Pearson S., Tester I.A., Klarquist J., Palmer B.E., Pawlotsky J.-M., Golden-Mason L., Rosen H.R. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J. Virol. 2008, 82:1827.
33. Söderholm J., Ahlén G., Kaul A., Frelin L., Alheim M., Barnfield C., Liljeström P., Weiland O., Milich D.R., Bartenschlager R., Sällberg M. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 2006, 55:266.
34. Teutsch S., Luciani F., Scheuer N., McCredie L., Hosseiny P., Rawlinson W., Kaldor J., Dore G.J., Dolan K., Ffrench R., Lloyd A., Haber P., Levy M. Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Publ. Health 2010, 10:633.
35. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001, 194:1395.
36. Von Hahn T., Yoon J.C., Alter H., Rice C.M., Rehermann B., Balfe P., McKeating J.A. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007, 132(2):667.
37. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11(7):791.
38. +, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. Blood 2004, 103:2238.
39. + T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J. Immunol. 2009, 183:2827.
40. Zhong J.P., Gastaminza G.C., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. 2005, 102:9294.